abstract |
The present invention relates to the insertion of an MHC class I, MHC class II or β2 microglobulin upstream promoter sequence into a lentiviral vector to increase viral titer. The present invention encompasses these vectors, methods for making the vectors, and methods for using the vectors including pharmaceutical uses. |